Detailled Information

Name of the Instrument/Tool The Fibromyalgia Impact Questionnaire (FIQ)
First Description

Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol, 1991 May;18(5):728-33.

Year 1991
Domains
Concept of constructs Anxiety and depression, Fatigue, Global assessment, Pain, Physical function, Social Function
Population/Disease Disease specific
Originally developed for Fibromyalgia (FM)
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language Arabic, Bulgarian, Croatian, Czech, Danish, Dutch, English, Estonian, Filipino, Finnish, French, Georgian, German, Greek, Hungarian, Irish, Italian, Korean, Lithuanian, Macedonian, Maltese, Montenegrin, Norwegian, Polish, Portuguese, Romanian, Russian, Serbian, Slovak, Slovenian, Spanish, Swedish, Turkish, Ukrainian
REFERENCE IDENTIFICATION
Author/s Burckhardt CS, Clark SR, Bennett RM
Title The fibromyalgia impact questionnaire: develpment and validation
Journal J Rheumatol
Year 1991
Vol 18
Num 5
Pages 728-33
Country USA
Language English
Other references of interest
Link https://www.ncbi.nlm.nih.gov/pubmed/16273800
Brief Description

A review of the FIQ from 1991 to 2005

Instrument/Tool Translations References
Link https://www.ncbi.nlm.nih.gov/pubmed/12942697
Brief Description

Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I)

Link https://www.ncbi.nlm.nih.gov/pubmed/24166211
Brief Description

Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P).

Link https://www.ncbi.nlm.nih.gov/pubmed/8724306
Brief Description

Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the Fibromyalgia Impact Questionnaire.

DEVELOPER CONTACT INFORMATION
Correspondence to Robert Bennett
E-Mail bennetrob1@comcast.net
Address Division of arthritis and Rheumatic Diseases. Department of Medicine L329A . Oregon Health and Science University. 3181 SW Sam Jackson Park Rd, Portland, OR 97201-3098 USA.
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

It tests the ability to perform large muscle tasks, work difficulty, pain, fatigue, morning tiredness, stiffness, anxiety and depression.

Number of Items 10 items (one question per item, except 1 has 11 questions)
Range 0-100
Responses options/scale No
Developed for Both
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score

Score Interpretation:

The FIQ is scored in such a way that a higher score indicates a greater impact of the syndrome on the person. Each of the 10 items has a maximum possible score of 10. Thus the maximum possible score is 100. The average fibromyalgia patient scores about 50; severely afflicted patients are usually 70 plus.

The questionnaire is scored in the following manner:

1. The first item consists of 11 questions that make up a physical function scale. The 11 questions are scored and added to yield one physical impairment score. Each item is rated on a 4 point Likert type scale. Raw scores on each item can range from 0 (always) to 3 (never) – thus  the highest total possible raw scores 33. Because some patients may not perform some of the tasks listed, they are given the option of deleting items from scoring. In order to obtain a valid summed score for questions 1 through 11, the scores for the items that the patient has rated are summed and divided by the number of items rated (e.g. if the patient completed only 9 items at a score of 2 for each, the final score would be 9x2/9 =2). An average raw score between 0 and 3 is obtained in this manner.

2. Item 2 is scored inversely, so that a higher number indicates impairment (i.e., 0=7, 1=6, 2=5, 3=4, 4=3, 5=2, 6=1 and 7=0, etc.). Raw scores can range from 0 to 7.

3. Item 3 is scored directly (i.e. 7=7 and 0=0). Raw scores can range from 0 to7.

4. Items 4 through 10 are scored in 10 increments. Raw scores can range from 0 to 10. If the patient marks the space between two vertical lines on any item, that item is given a score that includes 0.5.

5. Once the initial scoring has been completed, the resulting scores are subjected to a normalization procedure so that all scores are expressed in similar units. The range of normalized scores is 0 to 10, with 0 indicating no impairment and 10 indicating maximum impairment.

In order to maintain a maximum possible score of 100 it is necessary to employ an "equalization calculation" if a  patient does not answer all 10 items. If one or more items are missed, the final summative score needs to by multiplied by 10/x. (e.g. if one question is missed multiply by 10/9 [i.e. 1.111], if 2 questions are missed multiply by 10/8 [i.e. 1.25, etc.] )

Score Interpretation ---
Cut-off points ---
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient 0 minutes
Scoring time by the assessor 0 minutes
Training to score Not necessary
Strengths Useful in clinical practice & research, Widely used
Limitations ---
OTHER COMMENTS
Other Comments

Problems with the FIQ

The FIQ was developed originally from a fibromyalgia clinic population that was predominantly female. Thus it may have a gender bias, particularly in item 1, in which 4 out of the 11 sub-items are often considered to be more likely to be performed by women, besides one study that report on the physical functioning subscale of the FIQ (i.e. item 1) between men and women and found no difference (6.8 ± 1.9 and 5.5 ± 2.7).

Wolfe et al. performed a Rasch analysis on more than 2500 patients from 4 sites (3 US, 1 Israel) who had completed the FIQ, the SF 36 and 4 versions of the HAQ. In scoring the FIQ, items are either rated on a Likert scaling or on a 0-10 VAS, thus all items have the same weight in the final scoring.

The FIQ tends to underestimate function impairment by its use of activities not usually performed.